Could Better Blood Pressure Control Save Half a Million Lives Every Year?

What if more than half a million cardiovascular deaths could be prevented every year—not through a revolutionary new treatment, but by making better use of what we already know?

That’s the striking message from research presented at the American Heart Association’s Hypertension Scientific Sessions 2026 [1].

Analyzing data from 20 countries, researchers estimated that 518,476 cardiovascular deaths could be prevented annually by expanding effective blood pressure management to approximately 80% of eligible adults.

Why Are 80% of People with Hypertension Still at Risk?

Despite decades of scientific advances, only one in five adults with hypertension in the countries studied had their blood pressure adequately controlled.

Researchers evaluated six established preventive healthcare interventions, including blood pressure management, cholesterol treatment, diabetes management, and cancer screening.

Improving blood pressure control offered the greatest estimated reduction in cardiovascular deaths—surpassing the projected benefits of expanding cholesterol treatment or improving blood sugar management.

The findings underscore an extraordinary opportunity: We already have the knowledge to prevent many cardiovascular deaths. The challenge is putting that knowledge into practice.

The Power of Nutrition to Support Healthy Blood Pressure

Blood pressure is one of the most important—and manageable—cardiovascular risk factors.

While medical care remains essential for treating hypertension, growing scientific interest in nutrition and vascular health continues to explore how naturally occurring plant compounds may support cardiovascular wellness.

One ingredient of particular interest is MegaNatural-BP®, the proprietary grape seed extract in Olivino Essential [2].

In a published randomized, placebo-controlled clinical trial involving 27 adults with metabolic syndrome, researchers investigated daily doses of 150 mg and 300 mg of MegaNatural-BP over four weeks. Both treatment groups experienced reductions in systolic and diastolic blood pressure, while the placebo group showed little change [3]. Although the study was small, the findings were encouraging.

Building on earlier research, a newer clinical trial at the Illinois Institute of Technology is investigating 150 mg daily of MegaNatural-BP, examining blood pressure, vascular function, and other cardiovascular risk factors. Results have not yet been published [4].

Olivino® Essential combines four scientifically studied Mediterranean bioactives to support healthy blood pressure, circulation, vascular function, and overall cardiovascular wellness.

Real Results from Real People

Hearing how Olivino Essential is making a difference in our customers’ lives brings science to life.

“It works. My BP is down…. Been taking this for less than 30 days or so and my BP is down from 142/92 to 125/82. The doctor was happy but not as happy as I was when the nurse took my reading today.”

— Ramona S.

A Powerful Reminder About Prevention

The real significance of this research extends beyond the numbers.

It reminds us that cardiovascular health deserves attention long before a medical crisis occurs—and that applying established knowledge can have an extraordinary impact.

More than half a million potentially preventable deaths each year is a compelling reason to make blood pressure control a priority.

At OlivinoLife, we’re committed to advancing that conversation through science-based nutrition and a focus on lifelong cardiovascular wellness.

Discover Olivino Essential

To your good health!

References:

[1] American Heart Association. (2026, October 11). Managing high blood pressure could prevent >500K CVD deaths annually in 20 countries. Hypertension Scientific Sessions 2026, Oral Presentation #89. American Heart Association.

[2] PLT Health MegaNatural-BP.

[3] Sivaprakasapillai B, Edirisinghe I, Randolph J, Steinberg F, Kappagoda T. (2009). Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism, 58(12), 1743–1746.

[4] Illinois Institute of Technology. (n.d.). MegaNatural BP® GSE on blood pressure and cardiometabolic risk factors. ClinicalTrials.gov, NCT06555952.


Olivino Essential is not intended to treat hypertension or replace prescribed medical care.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About the Author

Clare Hasler-Lewis, Ph.D., MBA, is CEO and Co-Founder of OlivinoLife, Inc., a nutrition scientist, entrepreneur, and a recognized authority on functional foods and health. Known as the “First Lady of Functional Foods,” she previously served as Founding Executive Director of the Robert Mondavi Institute for Wine and Food Science at UC Davis and the Functional Foods for Health Program at the University of Illinois. She has more than 30 years of experience translating nutrition science into practical health and commercial applications. She currently serves on the Board of Directors of CogniBiome Therapeutics and previously served on the Board of Directors of Chiquita Brands International.

 

Back to blog